1. Stocks
    2. /
  2. Novo Nordisk (NYSE: NVO)
    3. /

Novo Nordisk (NYSE: NVO) Share Price and News

$49.64 $0.87 (1.8%) 28 July 2026 at 5:58:56 am AEST

Novo Nordisk Chart and Price Data

About Novo Nordisk

Last updated 28-07-2026, 05:58:56am AEST
Current Price $49.64
Change $0.87 (1.8%)
Close Price $49.64
Open Price $49.18
Bid $49.55
Ask $50.00
Day Range $48.81 - $49.95
Year Range $35.12 - $64.16
Volume 17
Average Volume 12,983,359
Market Cap $166,790,866,600.00
Earnings Per Share $4.26

    • Novo Nordisk (NYSE: NVO)
    Latest News

    a smiling picture of legendary US investment guru Warren Buffett.
    Exchange-Traded Funds (ETFs)

    Invest like Warren Buffett with these top ASX ETFs

    | James Mickleboro

    These funds give investors an easy way to invest like the Oracle of Omaha.

    Read more »

    A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
    Exchange-Traded Funds (ETFs)

    3 world-class ETFs for Australian investors

    | James Mickleboro

    Want to invest in the best? These funds could be worth a look.

    Read more »

    Group of young people stacking hands together in an outdoor setting. A community of multiracial international people supporting each other.
    Exchange-Traded Funds (ETFs)

    3 ASX ETFs that could be perfect for beginner investors

    | James Mickleboro

    If you're new to the world of investing then it could be worth checking out these funds.

    Read more »

    A doctor appears shocked as he looks through binoculars on a blue background.
    Healthcare Shares

    Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?

    | Kevin Gandiya

    Novo Nordisk just lost $100 billion in market value.

    Read more »

    A person eats a meat pie on the beach... what's more Australian than that?
    Consumer Staples & Discretionary Shares

    Which ASX shares could be next on the menu for Ozempic?

    | Mitchell Lawler

    This broker believes the market for weight-loss drugs could grow tenfold. What could it consume on its way up?

    Read more »

    Shot of two young scientists using a laptop in a laboratory.
    Healthcare Shares

    How can ASX investors buy the US stock the WHOLE world is talking about?

    | Sebastian Bowen

    Want to know how to buy the international stock du jour from the comfort of the ASX? Read on!

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Exchange-Traded Funds (ETFs)

    'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs

    | James Mickleboro

    This could be your way to invest in obesity drugs.

    Read more »

    Profile

    since

    Note